ECONSALUT
Critical comments on health economics and policy
29 de juliol 2022
Against patents, again (3)
›
Patent Politics. Life Forms, Markets, and the Public Interest in the United States and Europe Comparing battles over patents on animals, hu...
28 de juliol 2022
Against patents (2)
›
Medical Monopoly. Intellectual Property Rights and the Origins of the Modern Pharmaceutical Industry Medical Monopoly combines legal, medic...
25 de juliol 2022
On epigenetics and health (2)
›
The Epigenetics Revolution. How Modern Biology Is Rewriting Our Understanding of Genetics, Disease, and Inheritance The ‘epi’ in epigenetic...
20 de juliol 2022
Covid-19 response
›
Covid-19. La respuesta autoritaria y la estrategia del miedo
14 de juliol 2022
Pharma, big pharma (14)
›
Global Pharmaceutical Policy
13 de juliol 2022
Pharma, big pharma (13)
›
Studies on Competition and Antitrust Issues in the Pharmaceutical Industry
12 de juliol 2022
Pharma, big pharma (12)
›
Antitrust in Pharmaceutical Markets & Geographical Rules of Origin
11 de juliol 2022
Pharma, big pharma (11)
›
EU Law of Competition and Trade in the Pharmaceutical Sector
10 de juliol 2022
Facing Covid-19
›
The Courage to Face COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex
09 de juliol 2022
Obamacare revisited
›
Crossing the American Health Care Chasm. Finding the Path to Bipartisan Collaboration in National Health Care Policy
08 de juliol 2022
Environmental impact on population health
›
Environmental Policy and Public Health. Principal Health Hazards and Mitigation
07 de juliol 2022
Amartya Sen legacy
›
Home in the World: A Memoir
06 de juliol 2022
AI everywhere (16)
›
Machines Behaving Badly: The Morality of AI
05 de juliol 2022
What are the keys to human progress?
›
The Journey of Humanity: The Origins of Wealth and Inequality
‹
›
Inici
Visualitza la versió per a web